We discovered and designed composite biomarkers for more successful clinical trials
We explored genes and gene-signature interactions to identify and explain treatment responses with Checkmate Pharmaceuticals
There is a bottleneck in biomarker discovery
The customer: Checkmate Pharmaceuticals
Technology + services
Simple models more accurately predict and explain treatment responses
Flexibility to suit your needs
Data access + data processing
High-performing + interpretable results
Regularly compliance + approval
What people are saying…
Looking for more?
Just because you can predict what’s going to happen does not mean you have an explanation for the phenomenon.